The Liver Meeting 2022-Portal Hypertension Debrief

Video Transcription

Video Summary

The video transcript discusses various studies and findings related to portal hypertension. The presenter discusses surrogate markers for portal pressure and the validation of the Bebeno7 criteria for identifying portal hypertension. The use of tamponade strategies for variceal bleeding and the effectiveness of rescue tips following tamponade are also discussed. The role of balloon-occluded retrograde transvenous obliteration (BRTO) in primary prophylaxis of gastric varices is explored, as well as the impact of combining statins and non-selective beta blockers in cirrhosis patients. The relationship between hepatic encephalopathy and inflammation is investigated, along with the potential benefits of albumin infusions and the use of telemedicine in monitoring liver transplant candidates. The relevance of physical fitness, including frailty and sarcopenia, in liver transplant candidates is discussed, as well as the impact of tips and sarcopenia on patient outcomes. Other topics covered include acute kidney injury, vasoconstrictive therapy, and the use of Turley pressin in hepatorenal syndrome.

Asset Caption

Presented by Dr. Andres Duarte-Rojo, Division of Gastroenterology and Hepatology, Northwestern University

The goal of the Portal Hypertension debrief is to provide a summary of the most influential research on portal hypertension presented during the AASLD. Abstracts with the highest potential to impact daily clinical practice will be included in the presentation.

Keywords

portal hypertension

surrogate markers

tamponade strategies

BRTO

cirrhosis patients

hepatic encephalopathy

liver transplant candidates